RENVELA
Live / Registered — Registered and renewed (as of 05 May 2018)
What this means for you
Registered since 30 Oct 2007. The owner can stop confusingly similar uses in the classes it covers; it stays on the register as long as the owner keeps up the maintenance filings (next due by 30 Oct 2017).
Record
- Serial number
- 78674340
- Registration number
- 3326463
- Mark type
- Stylized text
- Filed
- 20 Jul 2005
- Published for opposition
- 18 Apr 2006
- Registered
- 30 Oct 2007
- Next maintenance due
- 30 Oct 2017
- Attorney of record
- Karen Lim
Goods and services
- Class 005 — Pharmaceuticals: PHOSPHATE BINDERS FOR TREATMENT OF HYPERPHOSPHATEMIA
Owner
- GENZYME CORPORATION, Cambridge, MA, US
- GENZYME CORPORATION, Cambridge, MA, US
- GENZYME CORPORATION, Cambridge, MA, US
Prosecution history
- 08 Jan 2020 — REVIEW OF CORRESPONDENCE COMPLETE - ADDRESS UPDATED
- 10 Dec 2019 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 12 Apr 2019 — APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
- 12 Apr 2019 — TEAS CHANGE OF OWNER ADDRESS RECEIVED
- 05 May 2018 — NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
- 05 May 2018 — REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
- 05 May 2018 — REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
- 05 May 2018 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
- 25 Apr 2018 — TEAS SECTION 8 & 9 RECEIVED
- 05 Apr 2017 — REVIEW OF CORRESPONDENCE COMPLETE - ADDRESS UPDATED
- 31 Jan 2017 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 30 Oct 2016 — COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
- 19 Sept 2013 — NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
- 19 Sept 2013 — REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
- 10 Sept 2013 — REGISTERED - SEC. 8 (6-YR) & SEC. 15 FILED